Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | NYSE Arca Biotechnology |
| Investment focus | Aandelen, Verenigde Staten, Gezondheidszorg |
| Fund size | EUR 11 m |
| Total expense ratio | 0,60% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | No |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 24,04% |
| Inception/ Listing Date | 27 mei 2020 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ierland |
| Fund Provider | First Trust |
| Fund Structure | Public Limited Company |
| UCITS compliance | Yes |
| Administrator | BNY Mellon Fund Services (Ireland) Designated Activity Company |
| Investment Advisor | First Trust Advisors L.P. |
| Custodian Bank | The Bank of New York Mellon SA/NV, Dublin Branch |
| Revision Company | PwC |
| Fiscal Year End | 31 december |
| Swiss representative | Oligo Swiss Fund Services SA |
| Swiss paying agent | BANQUE CANTONALE DE GENÈVE |
| Germany | 30% belastingvermindering |
| Switzerland | ESTV Reporting |
| Austria | Belastingrapportagefonds |
| UK | UK-rapportage |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| EXACT Sciences | 4,93% |
| Natera | 4,00% |
| Illumina | 3,97% |
| Bruker | 3,93% |
| Regeneron Pharmaceuticals | 3,92% |
| Veracyte | 3,86% |
| ACADIA Pharmaceuticals | 3,54% |
| Incyte | 3,54% |
| Biogen | 3,52% |
| Waters | 3,46% |
| Verenigde Staten | 85,72% |
| Duitsland | 2,76% |
| Ierland | 2,65% |
| Anders | 8,87% |
| Gezondheidszorg | 91,13% |
| Anders | 8,87% |
| YTD | +2.19% |
| 1 month | -3.98% |
| 3 months | -1.13% |
| 6 months | +18.66% |
| 1 year | +5.18% |
| 3 years | +24.38% |
| 5 years | +25.73% |
| Since inception (MAX) | +20.75% |
| 2025 | +9.60% |
| 2024 | +12.26% |
| 2023 | -1.30% |
| 2022 | +1.20% |
| Volatility 1 year | 24.04% |
| Volatility 3 years | 20.23% |
| Volatility 5 years | 22.12% |
| Return per risk 1 year | 0.22 |
| Return per risk 3 years | 0.37 |
| Return per risk 5 years | 0.21 |
| Maximum drawdown 1 year | -22.44% |
| Maximum drawdown 3 years | -24.57% |
| Maximum drawdown 5 years | -24.57% |
| Maximum drawdown since inception | -25.05% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| Borsa Italiana | EUR | FBT | FBT IM FBTINAV | FBT.MI | |
| London Stock Exchange | GBX | FBT | FBT LN FBTINAV | ||
| London Stock Exchange | GBP | - | FBT LN | ||
| London Stock Exchange | USD | FBTU | FBTU LN FBTINAV |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 48 | 0.35% p.a. | Distributing | Sampling |